Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1994-10-14
1996-08-27
Kight, III, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514 54, 514 53, 514567, 530402, 536 53, 536116, 5361231, 53612313, 435238, 435193, 435195, A01N 4740, C08B 3700, C07K 100, C12N 706
Patent
active
055501559
ABSTRACT:
Monofucosylated and monosialyated derivatives of the compound .beta.Gal(1-4).beta.GlcNAc(1-3).beta.Gal(1-4).beta.GlcNAc-OR, where R is hydrogen, a saccharide, an oligosaccharide or an aglycon moiety have been found to be useful in modulating a cell-mediated immune inflammatory response in mammals.
REFERENCES:
patent: 4137401 (1979-01-01), Lemieux et al.
patent: 5032519 (1991-07-01), Paulson et al.
patent: 5079353 (1992-01-01), Ratcliff et al.
patent: 5374655 (1994-12-01), Kashem et al.
Gross et al; Biochem (1989) vol. 28 pp. 7386-7392.
Paulsen, Hans; Agnew Chem. Int Ed. Engl. 21(1982) pp. 155-173.
Schauer et al; "Sialic Acids"; 1988, pp. 20-21.
Okamoto et al; Tetrahedron vol. 46, No. 17, pp. 5835-5857 (1990).
Reuter et al; Glycoconjugate Jour, (1988) 5: pp. 133-135.
Kashem Mohammed A.
Smith Richard
Venot Andre P.
Alberta Research Council
Kight III John
Leary Louise N.
LandOfFree
Methods for the synthesis of monofucosylated oligosaccharides te does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the synthesis of monofucosylated oligosaccharides te, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the synthesis of monofucosylated oligosaccharides te will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1056509